PMDA drug package insert
弘真胃腸薬S
PMDA OTC drug · 大草薬品販売（株） · package insert Aug 18, 2023
Key facts
| Brand names | 弘真胃腸薬S |
|---|---|
| Companies | 製造販売元／大草薬品（株）,販売会社／大草薬品販売（株） |
| Product type | OTC drug |
| OTC risk class | 第３類医薬品 |
| OTC dosage form | 散剤 |
| OTC effect category | 制酸・健胃・消化・整腸を2以上標榜するもの |
| Package insert date | Aug 18, 2023 |
| PMDA document key | 180021_J0601002746 |
| PMDA company code | 180021 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: